MARKET

ATHX

ATHX

Athersys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.880
+0.140
+5.11%
After Hours: 2.880 0 0.00% 19:31 04/03 EDT
OPEN
2.790
PREV CLOSE
2.740
HIGH
3.070
LOW
2.380
VOLUME
9.23M
TURNOVER
--
52 WEEK HIGH
4.380
52 WEEK LOW
1.130
MARKET CAP
472.74M
P/E (TTM)
-9.7693
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ATHX stock price target is 9.00 with a high estimate of 12.00 and a low estimate of 6.00.

EPS

ATHX News

More
  • Athersys Inc.: MultiStem Cell Therapy Is The Most Advanced And Tested Treatment For ARDS, And Thus COVID-19
  • Seeking Alpha - Article · 14h ago
  • LK, APA, DO and GMLP among midday movers
  • Seeking Alpha - Article · 1d ago
  • Don't Believe The Athersys Hype In ARDS
  • Seeking Alpha - Article · 1d ago
  • Edited Transcript of ATHX earnings conference call or presentation 16-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 2d ago

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About ATHX

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
More

Webull offers kinds of Athersys Inc stock information, including NASDAQ:ATHX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHX stock news, and many more online research tools to help you make informed decisions.